Use of data from the Vascular Quality Initiative registry to support regulatory decisions yielded a high return on investment
Background Real-world data (RWD) from the Society for Vascular Surgery Vascular Quality Initiative (VQI) registry has been used to support US Food and Drug Administration (FDA) regulatory decisions regarding vascular devices. The variables of cost and time needed for these registry-based studies hav...
Main Authors: | Art Sedrakyan, Gregory Pappas, Erika Avila-Tang, Danica Marinac-Dabic, Jack L Cronenwett, Adam W Beck, Daniel Bertges, Jens Eldrup-Jorgensen, Frederic S Resnic, Nadezda Radoja, Andreas Schick, Josh Smale, Roberta A Bloss, Peter Phillips, Melissa Hasenbank, Shengchun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Surgery, Interventions, & Health Technologies |
Online Access: | https://sit.bmj.com/content/2/1/e000039.full |
Similar Items
-
Authors’ response
by: Jack L Cronenwett, et al.
Published: (2020-11-01) -
Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing
by: Matheny Michael E, et al.
Published: (2011-12-01) -
International Validation of the Population Based Malta Vascular Registry: A Vascunet Report
by: Nikolaj Eldrup, et al.
Published: (2020-01-01) -
The Danish Vascular Registry, Karbase
by: Eldrup N, et al.
Published: (2016-10-01) -
COVID-19 has no effect on gravity
by: Peter McCulloch, et al.
Published: (2020-11-01)